News
The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.
British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...
19h
TipRanks on MSNGlaxoSmithKline Reports Strong Q2 2025 Performance
GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.
2d
BUCKSCO.Today on MSNGSK Partners with Chinese Pharma Co. in $500M Deal
Pharma giant Glaxosmithkline, which has major operations in Upper Providence and West Point, is partnering with China-based ...
GlaxoSmithKline downgraded full-year earnings expectations, as its second-quarter profit was hit by currency moves, weak sales of its respiratory drugs and the continuing bribery investigation in ...
GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.
Photo by Flickr user Ian Wilson Doctors will no longer be paid to speak on behalf of GlaxoSmithKline and its products, the British drug maker said Tuesday. In addition, the pharmaceutical company ...
Pharmaceutical comipany GlaxoSmithKline is under scrutiny following the death of children in Argentina. Parents believe that the experimental vaccines may be the cause of infant deaths.
As I looked into the story at the time, several things became clear: GlaxoSmithKline was promoting the drug for use by teenagers even though it had never been cleared by the FDA for anyone under ...
GlaxoSmithKline wants to better understand biology so it can discover more medicines, like every other drugmaker. It also wants to quit wasting money on drug candidates that look promising in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results